Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro

著录项

• 来源
  《中国药理学报：英文版》 |2014年第3期|401-409|共9页
• 作者

  Li-xian WU; Ying WU; Rui-jia CHEN; Yang LIU; Li-sen HUANG; Li-guang LOU; Zhi-hong ZHENG;

  展开▼
• 作者单位

  Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Institute of Materia Medica, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Fuijan Key Laboratory of Natural Medicine Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Institute of Materia Medica, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Fuijan Key Laboratory of Natural Medicine Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Institute of Materia Medica, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Institute of Materia Medica, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Fuijan Key Laboratory of Natural Medicine Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Department of Pharmacochemistry, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Institute of Materia Medica, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China;

  Shanghai Institute of Materia Medica,Shanghai 201203, China;

  Fujian Institute of Hematology, Union Hospital, Fujian Medical University, Fuzhou 350001, China;

  展开▼
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词